Atlas Trials

Santen Inc.

32 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Santen Inc.

RecordFirmDate
Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia (NCT05665387)Santen Inc.2022-12-22
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (NCT05376176)Santen Inc.2022-05-19
Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04742283)Santen Inc.2020-12-17
Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 (NCT03858894)Santen Inc.2019-01-28
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye (NCT03711929)Santen Inc.2018-11-19
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study (NCT03691662)Santen Inc.2018-09-27
DE-117 Spectrum 5 Study (NCT03697811)Santen Inc.2018-09-27
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study (NCT03691649)Santen Inc.2018-09-14

Track Santen Inc. automatically

Every clearance here is in the API, with alerts when new ones post.